日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.

双重抑制 BET 和 EP300 对未分化多形性肉瘤具有抗肿瘤活性,并与铁死亡诱导产生协同作用

Verbeke Stéphanie, Bourdon Aurélien, Lafon Mathilde, Chaire Vanessa, Frederic Bertolo, Naït Eldjoudi Amina, Derieppe Marie-Alix, Giles Francis, Italiano Antoine

Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial

博舒替尼治疗既往接受过治疗的慢性粒细胞白血病患者的疗效和安全性:BYOND试验的最终结果

Gambacorti-Passerini, Carlo; Brümmendorf, Tim H; Abruzzese, Elisabetta; Kelly, Kevin R; Oehler, Vivian G; García-Gutiérrez, Valentín; Hjorth-Hansen, Henrik; Ernst, Thomas; Leip, Eric; Purcell, Simon; Luscan, Gerald; Viqueira, Andrea; Giles, Francis J; Hochhaus, Andreas

Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study

年龄和合并症对既往接受过治疗的慢性粒细胞白血病患者使用博舒替尼的疗效和耐受性的影响:来自4期BYOND研究的结果

Rosti, Gianantonio; Brümmendorf, Tim H; Gjertsen, Björn T; Giraldo-Castellano, Pilar; Castagnetti, Fausto; Gambacorti-Passerini, Carlo; Ernst, Thomas; Zhao, Huadong; Kuttschreuter, Luke; Purcell, Simon; Giles, Francis J; Hochhaus, Andreas

SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer

SLAM修饰作为一种癌症免疫调节治疗方法

Tojjari, Alireza; Giles, Francis J; Vilbert, Maysa; Saeed, Anwaar; Cavalcante, Ludimila

Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma

9-ING-41(一种小分子选择性糖原合成酶激酶-3β (GSK-3β) 抑制剂)在难治性成人T细胞白血病/淋巴瘤中的临床活性

Hsu, Andrew; Huntington, Kelsey E; De Souza, Andre; Zhou, Lanlan; Olszewski, Adam J; Makwana, Nirav P; Treaba, Diana O; Cavalcante, Ludimila; Giles, Francis J; Safran, Howard; El-Deiry, Wafik S; Carneiro, Benedito A

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

莫西妥单抗帕苏多托克斯用于既往接受过大量治疗的复发/难治性毛细胞白血病(HCL)患者:关键性试验的长期随访

Kreitman, Robert J; Dearden, Claire; Zinzani, Pier Luigi; Delgado, Julio; Robak, Tadeusz; le Coutre, Philipp D; Gjertsen, Bjørn T; Troussard, Xavier; Roboz, Gail J; Karlin, Lionel; Gladstone, Douglas E; Kuptsova-Clarkson, Nataliya; Liu, Shiyao; Patel, Priti; Rotolo, Federico; Mitry, Emmanuel; Pastan, Ira; Giles, Francis

Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

一线尼洛替尼治疗慢性期慢性粒细胞白血病患者后达到无治疗缓解:ENESTfreedom试验5年更新

Radich, Jerald P; Hochhaus, Andreas; Masszi, Tamás; Hellmann, Andrzej; Stentoft, Jesper; Casares, María Teresa Gómez; García-Gutiérrez, J Valentín; Conneally, Eibhlin; le Coutre, Philipp D; Gattermann, Norbert; Martino, Bruno; Saussele, Susanne; Giles, Francis J; Ross, David M; Aimone, Paola; Li, Sai; Titorenko, Ksenia; Saglio, Giuseppe

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

一项针对罕见肿瘤患者(非胰腺神经内分泌肿瘤患者)的双重抗CTLA-4和抗PD-1阻断疗法的II期篮式试验(DART SWOG 1609)

Patel, Sandip P; Othus, Megan; Chae, Young Kwang; Giles, Francis J; Hansel, Donna E; Singh, Preet Paul; Fontaine, Annette; Shah, Manisha H; Kasi, Anup; Baghdadi, Tareq Al; Matrana, Marc; Gatalica, Zoran; Korn, W Michael; Hayward, Jourdain; McLeod, Christine; Chen, Helen X; Sharon, Elad; Mayerson, Edward; Ryan, Christopher W; Plets, Melissa; Blanke, Charles D; Kurzrock, Razelle

Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734

双重选择性溴结构域抑制剂NEO2734联合靶向NUT中线癌中的BRD4-NUT-p300轴

Morrison-Smith, Chevaun D; Knox, Tatiana M; Filic, Ivona; Soroko, Kara M; Eschle, Benjamin K; Wilkens, Margaret K; Gokhale, Prafulla C; Giles, Francis; Griffin, Andrew; Brown, Bill; Shapiro, Geoffrey I; Zucconi, Beth E; Cole, Philip A; Lemieux, Madeleine E; French, Christopher A

Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses

糖原合成酶激酶-3β抑制剂作为新型癌症治疗方法和抗肿瘤免疫反应调节剂

Sahin, Ilyas; Eturi, Aditya; De Souza, Andre; Pamarthy, Sahithi; Tavora, Fabio; Giles, Francis J; Carneiro, Benedito A